Page last updated: 2024-11-06

prednisolone and Osseous Paget's Disease

prednisolone has been researched along with Osseous Paget's Disease in 3 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rico, H1
Villa, LF1
Crisp, AJ1
Smith, ML1
Ghosh, ML1
Sayeed, A1

Other Studies

3 other studies available for prednisolone and Osseous Paget's Disease

ArticleYear
Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling.
    Calcified tissue international, 1993, Volume: 52, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Calcitonin; Cytarabine;

1993
Combination therapy with colchicine and prednisolone in Paget's disease of bone.
    British journal of rheumatology, 1988, Volume: 27, Issue:2

    Topics: Aged; Alkaline Phosphatase; Colchicine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged

1988
Unusual cases of myelomatosis.
    Scandinavian journal of haematology, 1974, Volume: 12, Issue:2

    Topics: Aged; Autopsy; Biopsy; Bone Marrow Cells; Cyclophosphamide; Female; Heart Neoplasms; Humans; Kidney

1974